Golub Capital Provides One-Loan Financing To Support Sagard Capital's Acquisition of IntegraMed America

NEW YORK, Sept. 20, 2012 /PRNewswire/ -- Golub Capital announced today that as Sole Lead Arranger and Sole Bookrunner it provided a $95 million GOLD financing and an equity co-investment in connection with the acquisition of IntegraMed America, Inc. (NASDAQ: INMD) ("IntegraMed"), a leader in developing, marketing and managing specialty healthcare facilities in the fertility and vein care markets, by Sagard Capital L.P. ("Sagard"). GOLD financings are Golub Capital's One-Loan Debt facilities.

"We are excited to support Sagard's acquisition of IntegraMed," stated Spyro Alexopoulos, Managing Director at Golub Capital.  "IntegraMed is an established market leader in the fertility and vein care markets that provides its physician practices and clinics a compelling value proposition. This represents our first transaction with Sagard. We were very impressed with their thoughtful approach to the business and have great confidence that they will deliver meaningful incremental value to IntegraMed under their ownership."

"It was a pleasure working with the Golub Capital team" stated Michael Braner, Partner at Sagard.  "Golub Capital distinguished itself to lead the financing on several fronts including speed of execution, certainty, flexibility and the ease of use of its GOLD product. The team quickly appreciated and understood the intricacies of the business model and was able to think creatively to provide the necessary flexibility to enable IntegraMed to execute their growth strategy."

About Golub Capital

With over $6 billion of capital under management, Golub Capital is a leading provider of financing solutions for the middle market, including one-loan financings (through the firm's proprietary GOLD facility), senior, second lien, and subordinated debt, preferred stock and co-investment equity. The firm underwrites and syndicates senior credit facilities up to $250 million. Golub Capital's hold sizes range up to $150 million per transaction.

Golub Capital has been a top 3 Traditional Middle Market Bookrunner each year from 2008 through 1H 2012 for senior secured loans of up to $100 million for leveraged buyouts (according to Thomson Reuters LPC and internal data; based on number of deals).. In 2012, Golub Capital was awarded the ACG New York Champion's Award for "Senior Lender Firm of the Year." Golub Capital is a national firm with principal offices in Chicago and New York. For more information, please visit the firm's website at www.golubcapital.com.

About Sagard Capital Partners, L.P.

Sagard Capital is a long-term investor in public and private small and mid-sized companies.  Sagard Capital is an evergreen fund with an indefinite holding period for its investments. Sagard specializes in flexible equity structures in minority and control positions that best address a company's needs. Sagard partners with management teams committed to driving long-term value, through a combination of capital, a global network of relationships, a team built to deliver value-added support, and a focus on building strong, sustainable leading businesses over the long term. Additional information may be found at www.sagardcapital.com.

About IntegraMed

IntegraMed is a leader in developing, marketing and managing specialty healthcare facilities in the fertility and vein care markets.  IntegraMed supports its provider networks with clinical and business information systems, marketing and sales, facilities and operations management, finance and accounting, human resources, legal, risk management, quality assurance, and fertility treatment financing programs.    

SOURCE Golub Capital



RELATED LINKS
http://www.golubcapital.com

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.